Capital International Inc. CA Has $18.65 Million Holdings in CVS Health Co. (NYSE:CVS)

Capital International Inc. CA increased its stake in CVS Health Co. (NYSE:CVS) by 49.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 415,408 shares of the pharmacy operator’s stock after acquiring an additional 136,976 shares during the quarter. Capital International Inc. CA’s holdings in CVS Health were worth $18,648,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of CVS. Capital World Investors raised its holdings in shares of CVS Health by 26.6% during the fourth quarter. Capital World Investors now owns 61,039,777 shares of the pharmacy operator’s stock valued at $2,739,927,000 after purchasing an additional 12,819,148 shares during the period. Claret Asset Management Corp increased its position in CVS Health by 10.4% in the 4th quarter. Claret Asset Management Corp now owns 301,743 shares of the pharmacy operator’s stock valued at $13,545,000 after buying an additional 28,500 shares in the last quarter. First Trust Advisors LP raised its stake in CVS Health by 16.3% during the 4th quarter. First Trust Advisors LP now owns 2,958,827 shares of the pharmacy operator’s stock worth $132,822,000 after buying an additional 413,987 shares during the period. Capital International Investors boosted its holdings in CVS Health by 4.8% in the fourth quarter. Capital International Investors now owns 26,666,401 shares of the pharmacy operator’s stock worth $1,196,989,000 after acquiring an additional 1,212,126 shares in the last quarter. Finally, Capital International Sarl increased its holdings in shares of CVS Health by 75.6% during the fourth quarter. Capital International Sarl now owns 47,151 shares of the pharmacy operator’s stock valued at $2,117,000 after acquiring an additional 20,306 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the business’s stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. The trade was a 47.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Michael F. Mahoney acquired 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now directly owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This trade represents a 320.65 % increase in their position. The disclosure for this purchase can be found here. Insiders own 0.24% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $67.19 on Friday. The firm’s 50-day simple moving average is $66.46 and its two-hundred day simple moving average is $58.77. CVS Health Co. has a 52 week low of $43.56 and a 52 week high of $71.45. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The company has a market cap of $84.71 billion, a PE ratio of 18.36, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Research analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 3.96%. CVS Health’s dividend payout ratio is currently 72.68%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CVS shares. Leerink Partnrs raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Robert W. Baird lifted their price target on CVS Health from $51.00 to $71.00 and gave the company a “neutral” rating in a research note on Tuesday, April 15th. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Finally, Mizuho lifted their target price on CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a research report on Wednesday, April 9th. Four analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $71.83.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.